SCHEMBL31064003

SCHEMBL31064003

CC(C)c1cnn2c(NC3CCN(C(=O)OCC4(F)CN(C(=O)OC(C)(C)C)C4)CC3)cc(Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 1/20 0.46
CDK7 P50613 1/20 0.46
CDK9 P50750 1/20 0.46
ALDH1A1 P00352 3/20 0.43
MAPT P10636 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CNR1 P21554 2/20 0.40
CCNT1 O60563 1/20 0.39
NOS1 P29475 1/20 0.38
NOS2 P35228 1/20 0.38
IDH1 O75874 1/20 0.38
IDH2 P48735 1/20 0.38
LMNA P02545 1/20 0.37
THRB P10828 1/20 0.37
KDM1A O60341 1/20 0.37
EHMT2 Q96KQ7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064031 0.92 CDK4 (0.55) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064110 0.90 CDK4 (0.45) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064032 0.90 CDK4 (0.45) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL14427502 0.90 ALDH1A1 (0.53) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064045 0.88 CDK4 (0.43) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064070 0.87 CDK9 (0.43) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064215 0.86 CDK4 (0.42) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064037 0.86 CDK4 (0.42) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31064079 0.85 MEN1 (0.35) CDK4CDK7CDK9ALDH1A1MAPT
SCHEMBL31063990 0.85 CDK9 (0.41) CDK4CDK7CDK9ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024175024-A1 NEW FUSED HETEROCYCLIC COMPOUND AS CDKS INHIBITOR AND USE THEREOF 杭州德睿智药科技有限公司 2024-08-29 WO disclosed